Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Heart Association
Grant: AHA-18IPA34170321
Cardiovascular Medical Research and Education Fund
Grant: NA
National Institutes of Health
Grant: 5T32HL007824-22
Training Program in Molecular and Cellular Cardiology
NHLBI NIH HHS
Grant: R01 HL158998
NHLBI NIH HHS
Grant: R01 HL133554
NHLBI NIH HHS
Grant: T32 HL007824
National Institutes of Health
Grant: 3R01HL133554-03S1
Combination Gene Therapy in Combating Pulmonary Arterial Hypertension
FWCI
2.22
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals